期刊
BIOACTIVE MATERIALS
卷 6, 期 11, 页码 4163-4175出版社
KEAI PUBLISHING LTD
DOI: 10.1016/j.bioactmat.2021.04.013
关键词
Bone regeneration in situ; Controlled delivery; Cell recruitment; Aptamer; BMP2
资金
- National Natural Science Foundation of China [81902219, 81672158, 81873999]
- National Key R&D Program of China [2016YFC1100100]
In situ tissue engineering utilizing a novel delivery system with sequential release of bioactive molecules has shown promising results in promoting bone regeneration and cell activities. The study demonstrates enhanced bone formation in critical-sized defects with the sequential release system, suggesting its potential as an ideal alternative for cell-free scaffold-based bone regeneration.
In situ tissue engineering is a powerful strategy for the treatment of bone defects. It could overcome the limitations of traditional bone tissue engineering, which typically involves extensive cell expansion steps, low cell survival rates upon transplantation, and a risk of immuno-rejection. Here, a porous scaffold polycaprolactone (PCL)/decellularized small intestine submucosa (SIS) was fabricated via cryogenic free-form extrusion, followed by surface modification with aptamer and PlGF-2(123-144)*-fused BMP2 (pBMP2). The two bioactive molecules were delivered sequentially. The aptamer Apt19s, which exhibited binding affinity to bone marrow-derived mesenchymal stem cells (BMSCs), was quickly released, facilitating the mobilization and recruitment of host BMSCs. BMP2 fused with a PlGF-2(123-144) peptide, which showed super-affinity to the ECM matrix, was released in a slow and sustained manner, inducing BMSC osteogenic differentiation. In vitro results showed that the sequential release of PCL/SIS-pBMP2-Apt19s promoted cell migration, proliferation, alkaline phosphatase activity, and mRNA expression of osteogenesis-related genes. The in vivo results demonstrated that the sequential release system of PCL/SIS-pBMP2-Apt19s evidently increased bone formation in rat calvarial critical-sized defects compared to the sequential release system of PCL/SIS-BMP2-Apt19s. Thus, the novel delivery system shows potential as an ideal alternative for achieving cell-free scaffold-based bone regeneration in situ.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据